Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank86
Studio
Year-over-Year Change

Free cash flow yield

Percentile
P86
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
2025-0.03%+95.7%
2024-0.66%-159.5%
20231.11%+18.7%
20220.93%+104.6%
2021-20.23%-563.8%
2020-3.05%+14.5%
2019-3.56%-63.4%
2018-2.18%+19.4%
2017-2.70%+83.7%
2016-16.63%-